---
title: "EVLO.US (EVLO.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/EVLO.US/news.md"
symbol: "EVLO.US"
name: "EVLO.US"
parent: "https://longbridge.com/zh-HK/quote/EVLO.US.md"
datetime: "2026-03-14T13:55:47.214Z"
locales:
  - [en](https://longbridge.com/en/quote/EVLO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EVLO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EVLO.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/EVLO.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/EVLO.US/news.md)


# EVLO.US (EVLO.US) — 相關新聞

### [EVLO finishes 4MW, 8MWh energy storage project in American Samoa, first of three, in partnership with Eastern Power Solutions.](https://longbridge.com/zh-HK/news/236053857.md)
*2025-04-15T12:22:15.000Z*
> In Montréal today, EVLO Energy Storage Inc. revealed the successful commissioning of an energy storage system in America

### [Seres Therapeutics Appoints Marella Thorell As New CFO Following Retirement Of David Arkowitz](https://longbridge.com/zh-HK/news/108637235.md)
*2024-02-26T12:22:03.000Z*
> Seres Therapeutics, a microbiome therapeutics company, has appointed Marella Thorell as its new CFO following the retire

### [Evelo Biosciences, Inc.(OTCPK:EVLO) dropped from S&P TMI Index](https://longbridge.com/zh-HK/news/104326508.md)
*2023-12-14T05:00:00.000Z*
> (marketscreener.com) Evelo Biosciences, Inc. dropped from S&P TMI Indexhttps://?

### [Thinking about buying stock in Palo Alto Networks, Walgreens Boots Alliance, Peraso, Evelo Biosciences, or Safe & Green Development?](https://longbridge.com/zh-HK/news/102700656.md)
*2023-11-17T14:32:08.000Z*
> (marketscreener.com) NEW YORK, Nov. 17, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PAN

### [Thinking about buying stock in Aldeyra Therapeutics, Alphabet Inc., DraftKings, Evelo Biosciences, or Enlivex Therapeutics?](https://longbridge.com/zh-HK/news/101786230.md)
*2023-11-06T14:32:07.000Z*
> (marketscreener.com) NEW YORK, Nov. 6, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALDX

### [Evelo Biosciences: EDP2939-101 Study Fails To Meet Endpoint; To Explore Strategic Alternatives](https://longbridge.com/zh-HK/news/100124141.md)
*2023-10-17T13:10:48.000Z*
> Evelo Biosciences, Inc. (EVLO) announced top-line results from Phase 2 clinical study with EDP2939 in moderate psoriasis